Alimera Sciences to Present at 36th Annual Cowen Healthcare Conference

ATLANTA, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ: ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Chief Executive Officer, Dan Myers, will present at the 36th Annual Cowen Healthcare Conference, to be held March 7-9, 2016 at the The Boston Marriott Copley Place, Boston, Massachusetts. Alimera Sciences' presentation will take place Wednesday, March 9, 2016 at 8:00 AM Eastern Time.

A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Relations" section of the Company's website at www.alimerasciences.com. A replay of the conference presentation will also be available.

About Alimera Sciences

Alimera Sciences (NASDAQ: ALIM) (Alimera), founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases.

For more information, please visit www.alimerasciences.com.

COCKRELL GROUP
877.889.1972
[email protected]
cockrellgroup.com

Source: Alimera Sciences, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Craig-Hallum Assumes Alimera Sciences (ALIM) at Buy
• Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)